Topic: How To Invest

What is Pat’s commentary for the week of September 10, 2024

Article Excerpt

The COVID-19 pandemic resulted in short-term disruptions to elective medical procedures. Despite that, hospital-equipment supplier Steris kept reporting rising revenue and profits. In fact, the stock went on to hit an all-time high of $252 in April 2022. It then retreated to about $160 later that year as supply-chain disruptions hurt the company. But the stock has rebounded since then, and we think it can return to its all-time high—and push past it. Going forward, the company is in position to profit from favourable long-term demographic trends such as an aging population. The recent sale of its Dental unit also sharpens its focus on its most lucrative markets. I asked our Successful Investor research department to draw up this Inner Circle Spotlight report on the stock. It explains why we feel Steris makes a solid addition to any investor’s portfolio. We hope you enjoy and profit from this Spotlight. Pat INNER CIRCLE SPOTLIGHT REPORT ON STERIS PLC Steris’s niches are lucrative and expanding STERIS PLC, $245.66,…